Clinical Trials Logo

Mastalgia clinical trials

View clinical trials related to Mastalgia.

Filter by:
  • None
  • Page 1

NCT ID: NCT06168110 Completed - Mastalgia Clinical Trials

A New Treatment Option for Mastalgia

Start date: February 1, 2020
Phase: N/A
Study type: Interventional

The main objective of this study is to determine the effectiveness of transcutaneous electrical nerve stimulation (TENS) treatment on pain and quality of life in mastalgia, which treatment has not yet reached a consensus.

NCT ID: NCT05456594 Completed - Neck Pain Clinical Trials

Comparing Sports Bra Design in Full Busted Women

Start date: June 20, 2022
Phase: N/A
Study type: Interventional

The goal of the current project is to assess performance of the Bounceless Control sports bra versus: (1) the Shefit Ultimate Sports bra, and (2) conventional bra as worn by participants in a variety of athletic activities.

NCT ID: NCT05408377 Recruiting - Mastalgia Clinical Trials

Effectiveness of Acupuncture for Cyclical Mastalgia (CM)

Start date: July 20, 2022
Phase: N/A
Study type: Interventional

This study is a multi-center 2-arm randomized controlled trial. According to the ratio of 1:1 and block randomization, a total of 108 eligible CM patients will be randomly allocated to either MA(n=54) or SA(n=54). All patients will undergo treatment two weeks before menstruation and treatment will be stopped at the onset of menstruation. Three times a week, six times a menstrual cycle, 3consecutive menstrual cycles for a total of 18 sessions after baseline. The primary outcome will be the change in the average daily breast pain VAS(VAS-BP) scores during the first 2 weeks of menstruation from baseline at weeks 4,8,12. Additionally, VAS-BP scores at weeks 24 and 36 will also be assessed. Secondary outcomes will include the number of nominal days of breast pain (NDBP) 2 weeks before menstruation, WHOQOL-BREF scores, patient global assessment, breast glandular section thickness, and breast duct width three days before menstruation from baseline at weeks 12. This study will evaluate the effectiveness and safety of acupuncture to alleviate cyclic breast pain and to further explore the possible mechanisms underlying the effect.

NCT ID: NCT04694027 Not yet recruiting - Mastalgia Clinical Trials

Omega-3 Fatty Acids Plus Vitamin E Cosupplementation Versus Vitamin E in Fibrocystic Breast Patient

FCC
Start date: January 2021
Phase: Phase 4
Study type: Interventional

to identify the effect of omega-3 plus vitamin E cosupplementation on mastalgia in patients with FCC and to compare its effect with that of vitamin E only.

NCT ID: NCT03936842 Not yet recruiting - Breast Pain Clinical Trials

Evaluation of an Educational Intervention for Women With Breast Pain

Start date: May 31, 2019
Phase: N/A
Study type: Interventional

Evaluation of an educational intervention for women with breast pain Target Problem -Symptomatic breast pain Study Objectives- The primary objective is to obtain knowledge of women's perceptions of an educational video about breast pain, breast awareness and self-examination and its impact on their confidence in self-management of breast pain. The secondary objectives -proportion of women who report that the video 1. Was informative 2. Might have reassured them enough not to have needed to seek an appointment in secondary care. Study Design- Prospective single-centre mixed methods study through semi-structured interviews for Masters in Public Health thesis Trial Population -Women, aged 18-40, referred to "one-stop" / rapid diagnostic breast clinic at The Royal Marsden Hospital (RMH) with breast pain alone. Recruitment target Until saturation, expected sample 10-15 Trial Design- Mixed methods study using semi-structured interviews Primary endpoint -This is a qualitative study, with no statistical primary end point. Secondary endpoints-Descriptive summaries of two questions will be reported as a secondary end point. Inclusion Criteria - Women aged between 18 years and 40 years on the day of clinic attendance - Breast pain as the only symptom - Normal clinical examination - No further investigation (imaging, biopsy etc) Exclusion Criteria - Presence of suspicious features during clinical examination requiring further investigation - Strong family history of breast cancer - Previous breast imaging within last 12 months - Previous history of breast cancer - Current or previous treatment with Tamoxifen - Concurrent cancer - Medical or psychiatric illness which might impact their participation in the study

NCT ID: NCT02784379 Completed - Mastalgia Clinical Trials

Electromyography of the Pectoral Muscle in Mastalgia Patients

Start date: March 2016
Phase: N/A
Study type: Observational

Mastalgia is a common problem for women. The aim of this study is to investigate the role of neuromuscular pathologies of the thorax wall at mastalgia ethiopathogenesis.

NCT ID: NCT01643837 Withdrawn - Mastalgia Clinical Trials

Mastalgia Treatment: Is There a Role for Osteopathic Manipulative Treatment

Start date: May 7, 2012
Phase: N/A
Study type: Interventional

There are many current medical treatments for mastalgia, but few have been proven effective. Our objective is to evaluate the effectiveness of osteopathic manipulative treatment as compared to a light touch protocol and standard management in the treatment of women with cyclical and non-cyclical mastalgia. We will compare duration of the pain, severity of the pain and the effect of the pain on quality of life.

NCT ID: NCT00999921 Completed - Clinical trials for Benign Breast Disease

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Start date: January 2008
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine the efficacy and relapse rate of low dose, short duration treatment with tamoxifen in benign breast disease amenable to hormonal therapy with respect to etiology and estrogen receptor status and to realize its side-effects and cost of therapy. To do a comparative analysis of the results with evening primrose oil which is one of the first line management in benign breast disease.